Iowa SF2312 amends the definition of "340B drug" and prohibits manufacturers and distributors from interfering with the acquisition or delivery of.
Iowa SF2312 amends the definition of "340B drug" to mean a covered outpatient drug for which a manufacturer has offered a reduced price and is purchased by a covered entity. The bill also defines "manufacturer" and "distributor" and prohibits a manufacturer or distributor from denying, restricting, or interfering with the acquisition of a 340B drug by a covered entity or the delivery of a 340B drug to a contract pharmacy, unless prohibited by the United States department of health and human services.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.